36 financial services, namely, asset management, advisory, research and analysis services; financial services, namely, asset management, advisory, research and analysis services related to life sciences; financial services, namely, asset management, advisory, research and analysis services related to health care; financial services, namely, asset management, advisory, research and analysis services related to clinical trials; financial services, namely, investment management, advisory, research and analysis services; financial services, namely, investment management, advisory, research and analysis services related to life sciences; financial services, namely, investment management, advisory, research and analysis services related to health care; financial services, namely, investment management, advisory, research and analysis services related to clinical trials; financial services, namely, commercial lending services; financial services, namely, commercial lending services in connection with life sciences; financial services, namely, commercial lending services in connection with health care; financial services, namely, commercial lending services in connection with clinical trials